Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yan Li
Institution:
Qilu Hospital of Shandong University
Observed institutions:
Shandong University,
Sichuan University,
West China Hospital of Sichuan University,
Fourth Hospital of Hebei Medical University,
The First People’s Hospital of Lianyungang,
Qilu Hospital of Shandong University,
State Key Laboratory of Biotherapy
show all 7
ORCID:
0000-0001-6749-5499
Observed ORCID:
0000-0001-6749-5499
OpenAlex ID:
A5100671503
Long non-coding RNA NNT-AS1 affects progression of breast cancer through miR-142-3p/ZEB1 axis
2018
·
Yan Li
, Min Lv
, et al.
·
Biomedicine & Pharmacotherapy
·
67
Aberrant promoter hypermethylation inhibits RGMA expression and contributes to tumor progression in breast cancer
2021
·
Yan Li
, Hai-Ting Liu
, et al.
·
Oncogene
·
26
Serine starvation suppresses the progression of esophageal cancer by regulating the synthesis of purine nucleotides and NADPH
2025
·
Hui Jie
, Jing Wei
, et al.
·
Cancer & Metabolism
·
15
PDF
Long non-coding RNA NRSN2-AS1, transcribed by SOX2, promotes progression of esophageal squamous cell carcinoma by regulating the ubiquitin-degradation of PGK1
2022
·
Tongxin Xu
, Zhaoyang Yan
, et al.
·
Clinical & Experimental Metastasis
·
15
Chondroitin sulfate-modified antiangiogenic peptide conjugate induces cell apoptosis via the mitochondria-mediated pathway to perform antitumor activity
2024
·
Yan Li
, Jiaai Fu
, et al.
·
International Journal of Biological Macromolecules
·
6
Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
2
Table S1 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S8 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S5 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S7 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S4 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S2 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S6 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S9 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S1 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S10 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Data from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Figure S3 from Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
2026
·
Hewei Wu
, Zhongxue Han
, et al.
Show more works
View as search
Works count:
18
Citation count:
131
H-index:
5
I10-index:
4
Year
Topic
Type